Sign up

AcclaimIP-ad

Match Document Document Title
US20140066517 USE OF CALIXARENES ASSOCIATED WITH AN ANTIBOTIC IN THE TREATMENT OF BACTERIAL INFECTIONS  
A product comprising a calixarene for its use in the treatment of pathologies involving at least one bacterial strain having a resistance to at least one defined antibiotic, on patients undergoing...
US20140199254 MULTIFUNCTIONAL HAIR COLOR PROTECTOR  
This invention relates to the synthesis of a multifunctional hair color protector, p-methoxy cinnamidoproyl dimethyl behenyl ammonium chloride of Formula I and the compositions containing the same...
US20130213393 NASAL FORMULATIONS OF METOCLOPRAMIDE  
Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with...
US20120009133 POLY (NON-CONJUGATED DIENE) BASED SUNSCREENS  
A poly(non-conjugated diene) based sunscreen has a plurality of repeating units where each repeating unit has at least one UV absorbing chromophore that is situated between and connected by chains...
US20130243920 Teeth color maintenance composition for addition into beverages  
Disclosed is a process and composition for teeth bleaching and color maintenance made up of a solution added to beverages (coffee, tea, wine, sodas). The method and composition offers and option to...
US20130190340 Small-Molecule-Targeted Protein Degradation  
Certain aspects of the invention relate to compounds, compositions and methods that are useful for treating or preventing a disease in a subject by enhancing the degradation of a protein. In other...
US20110230678 ORGANIC FRAMEWORK  
Disclosed is an organic framework including: planar layers formed by successively connecting building blocks arranged in the vicinity of each other, in which each of the building blocks includes...
US20140000807 ACCELERATORS FOR TWO STEP ADHESIVE SYSTEMS  
Benzoylthiourea or benzoylthiourethane derivatives as cure accelerators in primers for two step adhesive systems are provided.
US20130012591 PROPHYLAXIS OF SKIN CANCER WITH RETINAMIDES  
Provided in certain embodiments herein are methods of prophylaxis of skin cancer in individuals having a heightened risk of skin cancer with a fenretinide agent.
US20140001056 METHOD USING FLUORINATED AMPHIPHILES  
The invention relates to a method of inhibiting the insertion of one or more membrane proteins into a lipid bilayer. The invention also relates to a method of inserting a pre-determined number of...
US20120219538 STABILIZED PROTEIN FORMULATIONS AND USE THEREOF  
The present invention is directed to stable protein formulations, related methods and uses thereof. In particular, the invention relates to a method of stabilizing therapeutic proteins in aqueous...
US20130324409 CONTROL OF PLANT STRESS TOLERANCE, WATER USE EFFICIENCY AND GENE EXPRESSION USING NOVEL ABA RECEPTOR PROTEINS AND SYNTHETIC AGONISTS  
The present invention provides methods of regulating plant stress tolerance.
US20130089508 COMPOSITIONS FOR ENHANCING NAIL HEALTH  
The present invention is directed to compositions and methods for enhancing the health of nails and cuticles in a mammal, including humans. The compositions may be administered topically to the...
US20120004463 RESOLUTION OF 4,5-DIMETHOXY-1-(METHYLAMINOMENTHYL)-BENZOCYCLOBUTANE  
A method of resolving an important chemical intermediate, 4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane, comprises the following steps: reacting its two enantiomers of...
US20120108848 PROCESS FOR RESOLUTION OF 1-(3-HYDROXYPHENYL)-2-METHYLAMINO ETHANOL  
Resolution of the title compound to its active isomer (R)-1-(3-hydroxyphenyl)-2-methylamino ethanol with (R)-naproxen as a resolving agent.
US20110086818 METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITUS  
The invention features methods, compositions, and kits for selective inhibition of pain-and itch sensing neurons (nociceptors and pruriceptors) by drug molecules of small molecule weight, while...
US20120225144 Herbal Supplement Prepared From Geranium  
An extraction method for extracts of Geranium or Pelargonium with improved methylhexaneamine content is provided. The method involves separating the oil phase from the aqueous phase; concentrating...
US20140099662 PHOTOTOXICITY TEST METHOD  
The present invention provides a phototoxicity test method using human retinal pigment epithelial cells, and so on.
US20130236573 ESKETAMINE FOR THE TREATMENT OF TREATMENT-REFRACTORY OR TREATMENT-RESISTANT DEPRESSION  
The present invention is directed to methods for the treatment of treatment-refractory depression or treatment-resistant depression comprising administering to a patient in need thereof, a...
US20140178331 METHOD OF TREATING CEREBRAL HEMORRHAGE AND SUBARACHNOID HEMORRHAGE COMPRISING ADMINISTERING METAL CHELATORS TO THE UPPER ONE-THIRD OF THE NASAL CAVITY  
Methods for preconditioning and/or providing neuroprotection to the animal central nervous system against the effects of cerebral hemorrhage and subarachnoid hemorrhage. Therapeutic agents are...
US20120264719 DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR  
S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
US20120022294 Axomadol or a Metabolite Thereof for Use in the Treatment of Irritable Bowel Syndrome  
The invention relates to axomadol or a metabolite thereof for use in the treatment of irritable bowel syndrome.
US20130252936 PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME  
Compounds, compositions and methods for the treatment of retinal degenerative diseases, such as retinitis pigmentosa, Leber's congenital Amaurosis, Syndromic retinal degenerations, age-related...
US20080139831 Water Tolerant Emulsion Stabilizers  
An emulsion stabilizer is disclosed having a water tolerance value of between more than about 1.0 and equal or less than about 11.0.
US20140135528 Chemical Installation  
According to the present invention, a chemical installation is provided. The chemical installation comprises A first unit for providing a first aqueous waste stream comprising nitrobenzene;At least...
US20120078015 Chemical Installation  
According to the present invention, a chemical installation is provided. The chemical installation comprises A first unit for providing a first aqueous waste stream comprising nitrobenzene; At...
US20120277180 Cofactors and Methods for Use for Individuals  
Provided herein are methods and systems for identifying one or more cofactors such as vitamins for individuals based on the genetic makeup of the individual by detecting the presence or absence of...
US20120178704 PREVENTION AND TREATMENT OF COLON CANCER  
Stilbene compounds for the prevention and treatment of colon cancer or colon inflammation and methods of using same are provided.
US20130303656 Chlorhexidine Gluconate Containing Solvent Adhesive  
Methods for incorporating chlorhexidine salts into solvent based adhesives are described. The methods involve freeze drying an aqueous solution of the chlorhexidine salt and obtaining the...
US20090021160 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE, METHOD FOR PRODUCING SAME AND ORGANIC ELECTROLUMINESCENT DEVICE  
A material for an organic electroluminescence device which can be a cis-isomer or a trans-isomer of structural isomers, the content of the trans-isomer being more than that of the cis-isomer. The...
US20100331416 Use of Monochlorourea to Treat Industrial Waters  
The present invention comprises a method for controlling (e.g. inhibiting) or killing microorganisms in an aqueous environment. The method includes the addition of an effective amount of...
US20120148690 SKIN BARRIER FUNCTION RECOVERY ACCELERATOR  
A novel skin barrier function recovery acceleration method and accelerator are provided. The present invention provides a skin barrier function recovery accelerator that comprises a TRPA1 agonist...
US20120329661 Isotope Labeling-Assisted Quantification (iLAQ) of Biological Compounds  
The present invention relates to a plurality of isotopically labeled compounds (“tag isotopomers”) and individual labeled compounds, which are useful for labeling samples of analytes, such as bio...
US20120115723 Ballast Water Treatment System  
A composition for treating waters, e.g. ballast water or injection water for oil recovery, to kill in-situ aquatic invasive species comprises at least one biocide capable of killing both animal and...
US20130023056 EARLY DETECTION OF RECURRENT BREAST CANCER USING METABOLITE PROFILING  
A monitoring test for recurrent breast cancer with a high degree of sensitivity and specificity is provided that detects the presence of a panel of multiplicity of biomarkers that were identified...
US20140170216 BUPROPION HYDROBROMIDE POLYMORPHS  
Polymorphous and amorphous forms of bupropion hydrobromide are described.
US20130059005 BUPROPION HYDROBROMIDE POLYMORPHS  
Polymorphous and amorphous forms of bupropion hydrobromide are described.
US20120270296 ISOTOPE-DOPED NANO-STRUCTURE AND ISOTOPE LABELED STRUCTURE USING THE SMAE  
An isotope-doped nano-structure is provided. The isotope-doped nano-structure includes at least one isotope-doped nano-structure segment having at least two isotopes of the element. The at least...
US20110251289 NEW COMPOUNDS FOR THE TREATMENT OF CANCER  
The invention provides a method of preparing the stereoisomers of 1,11-diamino-6-aza-undecane-2,4,8,10-tetraol.
US20110123482 Methods of Treating Neurological Autoimmune Disorders with Cyclophosphamide  
Described herein are methods for treating neurological autoimmune disorders in which the treatment method includes administering an immunoablative agent to eliminate most or essentially all...
US20120172387 OPIOIDS FOR THE TREATMENT OF THE RESTLESS LEG SYNDROME  
The present invention relates to an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with restless leg syndrome (RLS).
US20110319516 RELEASE AGENT PARTITION CONTROL IN IMPRINT LITHOGRAPHY  
Release agents with increased affinity toward nano-imprint lithography template surfaces interact strongly with the template during separation of the template from the solidified resist in a...
US20140148415 DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST  
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.
US20140066657 DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST  
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage
US20130197041 GABR-A2 DIAGNOSTIC  
The present invention provides a method of selection of a patient, who is a candidate for treatment with an NMDA antagonist drug, such as (S)-1-phenyl-2-(pyridin-2-yl)ethanamine or ketamine,...
US20130047849 Organic Porous Materials Comprising Shape-Persistent Three-Dimensional Molecular Cage Building Blocks  
Porous bulk materials formed of shape-persistent, non-collapsible, three-dimensional molecular cage building blocks are presented that are useful for a variety of applications including gas...
US20130281462 ARYL DIAMIDINES AND PRODRUGS THEREOF FOR TREATING MYOTONIC DYSTROPHY  
Disclosed herein are compounds (for example, diamidine derivatives and prodrugs) and methods of use thereof, for example in treating muscular dystrophy (DM) or disease caused by a toxic RNA in a...
US20110201688 N,N'-DI-P-BROMOPHENYL GUANIDINE TREATMENT FOR STROKE AT DELAYED TIMEPOINTS  
1,3 di-o-tolylguanidine (DTG) was examined as anti-stroke drug with a broad therapeutic window. DTG activates sigma 1 and 2 receptors. Administration of DTG at 24 hours post-stroke to rats reduces...
US20120196894 NOVEL TRPA1 ANTAGONISTS  
The present invention relates to compositions and methods that modulate at least one TRP family member. Specifically, the present invention relates to novel TRPA1 antagonists and their use in the...
US20140093880 COMPOSITIONS, KITS, AND METHODS FOR ISOLATING VESICLES  
A composition, a kit, and a method of isolating a vesicle from a sample using a compound comprising zwitterion moieties, which may be used to analyze vesicles, and proteins, glycoprotein, lipids,...